[Efficacy and limits of the bariatric surgery].
Morbid obesity is associated with and increased risk of serious comorbidities, including type 2 diabetes, sleep apnoea, cardiovascular diseases, and orthopedic disabilities. Not operative treatments for superobese patients have not been shown to produce reliable long-term benefits, therefore surgical therapy has became the treatment of choice. The number of surgical procedures increased in the last year confirm these data. However, before recommended a specific surgical procedures to a superobese patients it is necessary to consider some variables, such as: patient, health structure, and multidisciplinary equipe. Since there are not recommended or condemned surgical procedures, in this paper the Authors tried to evaluate the effectiveness and limits of the most performed surgical procedures for the treatment of pathologic obesity: gastric by-pass, biliopancreatic diversion (duodenal switch), vertical gastroplasty, banding gastric. The Authors used some pointer of outcome to measure effectiveness and limits: five year post-operative percentage excess weight loss >/< 50, peri-operative >/< 1%, early and late complications >/< 15%, reoperation >/< 3%, improvement of quality of life. Thanks to new surgical technique, restrictive options are losing ground, while malabsorbitive bariatric procedures are collecting successful.
Albano
A
Nicolai
Marina
M
Taus
Debora
D
Busni
Massimiliano
M
Petrelli
D050110:Bariatric Surgery / Q000009:adverse effects / Q000401:mortality; D015992:Body Mass Index; D000075202:Contraindications; D005500:Follow-Up Studies; D015391:Gastroplasty / Q000009:adverse effects / Q000401:mortality; D006801:Humans; D009767:Obesity, Morbid / Q000150:complications / Q000601:surgery; D011183:Postoperative Complications; D011788:Quality of Life; D012086:Reoperation; D012307:Risk Factors; D013997:Time Factors; D015431:Weight Loss